Sanofi-Aventis appoints senior managers in emerging markets
This article was originally published in Scrip
Sanofi-Aventis has appointed a number of senior managers in emerging markets. Patrick Aghanian who is currently head of the company's operations in Russia is becoming head of the Eurasia region. Apart from Russia, he will take responsibility for business in Ukraine, Belarus and central Asia (centred in Kazakhstan). He has previously worked in the region for a number of companies, including GlaxoSmithKline, Novartis and Sandoz. Thomas Kelly who is currently head of greater China has been promoted to head Asia Region covering also Thailand, Singapore, Malaysia, Indonesia, Vietnam and the Philippines. Mr Kelly's previous jobs included marketing positions in Johnson&Johnson, Novo Nordisk and Schering-Plough. Heraldo Marchezini, head of Sanofi-Aventis's business in Brazil, has been promoted to head of the Latin America region, and the responsibilities of Jeremy Moulding, head the Japan & Pacific Region, have been expanded to cover South Korea.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.